Article
Statin therapy inhibits remyelination in the central nervous system.
The American journal of pathology - 1 May 2009
Miron Veronique E, Zehntner Simone P, Kuhlmann Tanja, Ludwin Samuel K, Owens Trevor, Kennedy Timothy E, Bedell Barry J, Antel Jack P
Abstract excerpt
Remyelination of lesions in the central nervous system contributes to neural repair following clinical relapses in multiple sclerosis. Remyelination is initiated by recruitment and differentiation of oligodendrocyte progenitor cells (OPCs) into myelinating oligodendrocytes. Simvastatin, a blood-brain barrier-permeable statin in multiple sclerosis clinical trials, has been shown to impact the in vitro processes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
